By Peter Nurse
Investing.com -- Stocks in focus in premarket trade on Wednesday, February 17th. Please refresh for updates.
Chevron (NYSE:CVX) stock rose 4.1% and Verizon (NYSE:VZ) stock climbed 3.9% after Warren Buffett's Berkshire Hathaway (NYSE:BRKa) revealed on Tuesday, via a regulatory filing, a $8.6 billion stake in the phone company and a $4.1 billion stake in the oil company.
Apple (NASDAQ:AAPL) stock fell 0.8% after Berkshire Hathaway reduced its stake in the iPhone maker, although at approximately $121 billion the tech giant remains by far its largest common stock holding.
- Salesforce (NYSE:CRM) stock fell 0.7% and Slack Technologies (NYSE:WORK) stock dropped 2.7% after the companies received requests for additional information from the antitrust division of the U.S. Department of Justice related to their $27.7 billion merger.
Ford (NYSE:F) stock rose 1% after the auto giant announced it would invest $1 billion over the next 30 months to ensure its car lineup in Europe will be all-electric by 2030.
Amazon (NASDAQ:AMZN) stock fell 0.3% despite the New York Attorney General announcing plans to sue the e-commerce giant over its handling of worker safety issues around the Covid-19 pandemic at two warehouses.
AIG (NYSE:AIG) stock fell 1.5% after the insurer posted a net loss of $60 million in the fourth quarter, mainly due to a $1.2 billion loss from derivatives.
Hilton Worldwide (NYSE:HLT) stock fell 2.5% after the hotel chain posted a surprise quarterly loss as bookings took a hit from a resurgence in Covid-19 cases and renewed travel curbs.
Shopify (NYSE:SHOP) stock fell 2% despite the e-commerce company reported a 94% jump in holiday quarter revenue, beating estimates as more businesses chose to sell online during the pandemic. The stock has risen around 25% over the last month.
Energy Transfer (NYSE:ET) stock rose 0.6% after the company announced plans to acquire Enable Midstream (NYSE:ENBL), down 4.5%, for $7 billion in an all-equity deal.
- Vir Biotechnology (NASDAQ:VIR) stock rose 11% after it announced that its Covid-19 antibody partnership with GlaxoSmithKline will be expanded to research therapies for other diseases.
- Garmin (NASDAQ:GRMN) stock rose 1.9% after the maker of fitness and navigation devices beat earnings and sales forecasts, seeing strong growth in most of its segments, led by marine and outdoor.